Status:
COMPLETED
Preventing Post-Stroke Depression
Lead Sponsor:
Robert G. Robinson
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Depression
Cerebrovascular Accident
Eligibility:
All Genders
31-89 years
Phase:
NA
Brief Summary
This study will evaluate the effectiveness of both drug and non-drug treatments in preventing depression after a stroke.
Detailed Description
The development of depression after a stroke is a serious condition that can have negative effects on thought, emotions, and overall daily functioning, particularly in the first year following the str...
Eligibility Criteria
Inclusion
- Stroke within the last 120 days
Exclusion
- DSM (Diagnostic and Statistical Manual) IV criteria for major or minor depressive disorder
- Heart, respiratory, kidney, or liver failure; severely disabling musculoskeletal disorder; or cancer
- Diagnosis of neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, Multiple System Atrophy, or Huntington's disease
- Pre-existing dementia or aphasia with severe language comprehension deficits
- Alcohol or substance abuse or dependence within the last 12 months
- Recurrent unipolar or bipolar disorder prior to the stroke
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
201 Patients enrolled
Trial Details
Trial ID
NCT00071643
Start Date
September 1 2002
End Date
November 1 2008
Last Update
September 5 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago
Chicago, Illinois, United States, 60637
2
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States, 52242-1000
3
Burke Rehabilitation Hospital
White Plains, New York, United States, 10605